Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 20Genitourinary 8Lymphoid 7Gastrointestinal 7Thoracic 6Gynecologic 6Tumor-Agnostic 3Other 3Dermatologic 3CNS 3Plasma cell 2Other hematologic neoplasm 2Sarcoma 1Head & Neck 1Endocrine 1Classical hematology 1

Conditions

Smoking Cessation 1Smoking 1Multiple Endocrine Neoplasia Type 1 1

Interventions

Everolimus 61lutetium Lu 177 dotatate 53Magnetic Resonance Spectroscopy 39pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 25lanreotide 24gallium Ga 68 dotatate 24cabozantinib 22pasireotide 21lenvatinib 203-Iodobenzylguanidine 20Etoposide 19Sunitinib 18Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18surufatinib 16Bevacizumab 16trametinib 15dabrafenib 15Sorafenib 14Doxorubicin 14Ipilimumab 13Thyrotropin Alfa 12Surgical Procedures, Operative 12Injections 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Behavioral Therapy × Endocrine × Clear all
NCT02055326 2014-02-05

Yoga for Men Attempting Smoking Cessation

The Miriam Hospital

Phase NA Completed
38 enrolled
Endocrine

Smoking, Smoking Cessation, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡